Distinct urinary glycoprotein signatures in prostate cancer patients (2018)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; LEITE, KATIA RAMOS MOREIRA - FM ; PALMISANO, GIUSEPPE - ICB
- Unidades: FM; ICB
- DOI: 10.18632/oncotarget.26005
- Subjects: PARASITOLOGIA; GLICOPROTEÍNAS; NEOPLASIAS; PRÓSTATA; BIOMARCADORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: OncoTarget
- ISSN: 1949-2553
- Volume/Número/Paginação/Ano: V. 9, N. 69, P. 33077-33097, 2018
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
KAWAHARA, Rebeca et al. Distinct urinary glycoprotein signatures in prostate cancer patients. OncoTarget, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.26005. Acesso em: 08 abr. 2026. -
APA
Kawahara, R., Ortega, F., Rosa-Fernandes, L., Guimarães, V., Quina, D., Nahas, W., et al. (2018). Distinct urinary glycoprotein signatures in prostate cancer patients. OncoTarget. doi:10.18632/oncotarget.26005 -
NLM
Kawahara R, Ortega F, Rosa-Fernandes L, Guimarães V, Quina D, Nahas W, Schwämmle V, Srougi M, Leite KRM, Thaysen-Andersen M, Larsen MR, Palmisano G. Distinct urinary glycoprotein signatures in prostate cancer patients [Internet]. OncoTarget. 2018 ;[citado 2026 abr. 08 ] Available from: https://doi.org/10.18632/oncotarget.26005 -
Vancouver
Kawahara R, Ortega F, Rosa-Fernandes L, Guimarães V, Quina D, Nahas W, Schwämmle V, Srougi M, Leite KRM, Thaysen-Andersen M, Larsen MR, Palmisano G. Distinct urinary glycoprotein signatures in prostate cancer patients [Internet]. OncoTarget. 2018 ;[citado 2026 abr. 08 ] Available from: https://doi.org/10.18632/oncotarget.26005 - Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia
- Protein paucimannosylation is an enriched N-gycosylation signature of human cancers
- Treating metastatic prostate cancer with microRNA-145
- PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- Prognostic value of TERF1 expression in prostate cancer
- Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer
- Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer
- Histologic abnormalities in non-neoplastic renal parenchyma and the risk of chronic kidney disease following radical nephrectomy
- Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
- Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
